AZD7325 single ascending dose study in healthy male Japanese subjects - JSAD

Study identifier:D1140C00010

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Phase I,Single-center,Randomised,Double-blind,Placebo-controlled Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7325 in Healthy Male Japanese Subjects

Medical condition

Healthy Volunteer

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD7325, Placebo

Sex

Male

Actual Enrollment

48

Study type

Interventional

Age

20 Years - 50 Years

Date

Study Start Date: 01 Oct 2008
Primary Completion Date: 01 Mar 2009
Study Completion Date: 01 Mar 2009

Study design

Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria